Clareon PanOptix Versus AcrySof PanOptix : Prospective Study Comparing Contrast Sensitivity

Visit at Day3-10: usual follow-up visit, no additional examinations as part of the clinical investigation.

Visit at 1 month: usual follow-up visit, no additional examinations as part of the clinical investigation.

3-month visit (end of clinical investigation): usual follow-up visit, plus contrast vision test and non-invasive aberrometry test (I-Trace) as part of the clinical investigation.

Regarding a cataract surgery with a request for presbyopia, the protocol evaluate two differents devices (IOL intraocular lens).

Inclusion criteria

• Patients ≥ 18 years of age
• Patients presenting for cataract surgery in routine clinical practice and eligible for multifocal IOL implantation (toric and non-toric)
• Patients with grade 2/3 cataract density and comparable visual acuity in both eyes
• Patient with a pregnancy test (negative pregnancy test), if applicable
• Patient with signed consent to participate in the study
• Patient affiliated to a social security scheme or entitled beneficiary

Exclusion criteria

• Children < 18 years of age
• Pregnancy or breast-feeding in progress or planned during the study.
• History of anterior (cornea, anterior chamber, sulcus) or posterior (uveal, vitreoretinal) segment pathology, including retinal vascular occlusive disease, retinal detachment or peripheral retinal laser photocoagulation, AMD, glaucoma.
• Any inflammation of the anterior or posterior segment, whatever the etiology, and/or history of any disease with intraocular inflammatory repercussions.
• Clinically significant corneal pathology (epithelial, stromal and/or endothelial) that could have an impact on visual results.
• Clinically significant moderate or severe dry eye that could affect study measurements.
• History of intraocular or corneal surgery (refractive or trauma-related).
• Presence or history of amblyopia or monofixation syndrome.
• Subjects with conditions that increase the risk of zonular disruption during the phacoemulsification procedure that may affect the centration or postoperative orientation of the IOL.
• Any other planned eye surgery, including, but not limited to, limbal relaxing incision (LRI)/astigmatic keratotomy and laser refractive surgery (LASIK).
• Irregular astigmatism identified by corneal topography
• Patients under guardianship, curatorship or safeguard of justice, as well as pregnant or breast-feeding women (article L1121-5 of the CSP).1.1
• Patient under AME